Related references
Note: Only part of the references are listed.Frequent administration of abaloparatide shows greater gains in bone anabolic window and bone mineral density in mice: A comparison with teriparatide
Akito Makino et al.
BONE (2021)
Activin type IIA decoy receptor and intermittent parathyroid hormone in combination overturns the bone loss in disuse-osteopenic mice
Mikkel Bo Brent et al.
BONE (2021)
Abaloparatide at the Same Dose Has the Same Effects on Bone as PTH (1-34) in Mice
Carole Le Henaff et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2020)
Fragility fractures in Europe: burden, management and opportunities
Fredrik Borgstrom et al.
ARCHIVES OF OSTEOPOROSIS (2020)
The Efficacy of PTH and Abaloparatide to Counteract Immobilization-Induced Osteopenia Is in General Similar
Mikkel Bo Brent et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Effects of abaloparatide and teriparatide on bone resorption and bone formation in female mice
Heike Arlt et al.
BONE REPORTS (2020)
Abaloparatide, a novel osteoanabolic PTHrP analog, increases cortical and trabecular bone mass and architecture in orchiectomized rats by increasing bone formation without increasing bone resorption
Heidi Chandler et al.
BONE (2019)
Abaloparatide exhibits greater osteoanabolic response and higher cAMP stimulation and β-arrestin recruitment than teriparatide
Karim Sahbani et al.
PHYSIOLOGICAL REPORTS (2019)
Disuse osteopenia induced by botulinum toxin is similar in skeletally mature young and aged female C57BL/6J mice
Jens Bay Vegger et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2018)
Abaloparatide, a novel PTH receptor agonist, increased bone mass and strength in ovariectomized cynomolgus monkeys by increasing bone formation without increasing bone resorption
N. Doyle et al.
OSTEOPOROSIS INTERNATIONAL (2018)
PTH (1-34) and growth hormone in prevention of disuse osteopenia and sarcopenia in rats
Mikkel Bo Brent et al.
BONE (2018)
Abaloparatide Exerts Bone Anabolic Effects with Less Stimulation of Bone Resorption-Related Factors: A Comparison with Teriparatide
Akito Makino et al.
CALCIFIED TISSUE INTERNATIONAL (2018)
Abaloparatide versus teriparatide: a head to head comparison of effects on fracture healing in mouse models
Magnus Bernhardsson et al.
ACTA ORTHOPAEDICA (2018)
One Year of Abaloparatide, a Selective Activator of the PTH1 Receptor, Increased Bone Formation and Bone Mass in Osteopenic Ovariectomized Rats Without Increasing Bone Resorption
Aurore Varela et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
Osteoporosis treatment: recent developments and ongoing challenges
Sundeep Khosla et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Parathyroid hormone's enhancement of bones' osteogenic response to loading is affected by ageing in a dose- and time-dependent manner
Lee B. Meakin et al.
BONE (2017)
One year of abaloparatide, a selective peptide activator of the PTH1 receptor, increased bone mass and strength in ovariectomized rats
Aurore Varela et al.
BONE (2017)
Binding Selectivity of Abaloparatide for PTH-Type-1-Receptor Conformations and Effects on Downstream Signaling
Gary Hattersley et al.
ENDOCRINOLOGY (2016)
Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis A Randomized Clinical Trial
Paul D. Miller et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Parathyroid hormone: anabolic and catabolic actions on the skeleton
Barbara C. Silva et al.
CURRENT OPINION IN PHARMACOLOGY (2015)
PTH receptor-1 signalling-mechanistic insights and therapeutic prospects
Ross W. Cheloha et al.
NATURE REVIEWS ENDOCRINOLOGY (2015)
Additive effect of PTH (1-34) and zoledronate in the prevention of disuse osteopenia in rats
Jens Bay Vegger et al.
BONE (2014)
Parathyroid hormone and parathyroid hormone type-1 receptor accelerate myocyte differentiation
Shigemi Kimura et al.
SCIENTIFIC REPORTS (2014)
Standardized Nomenclature, Symbols, and Units for Bone Histomorphometry: A 2012 Update of the Report of the ASBMR Histomorphometry Nomenclature Committee
David W. Dempster et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Critical role of parathyroid hormone (PTH) receptor-1 phosphorylation in regulating acute responses to PTH
Akira Maeda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Intermittent parathyroid hormone administration converts quiescent lining cells to active osteoblasts
Sang Wan Kim et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Bone disease in primary hyperparathyrodism
Claudio Marcocci et al.
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2012)
Molecular basis of parathyroid hormone receptor signaling and trafficking: a family B GPCR paradigm
Jean-Pierre Vilardaga et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Osteoporosis: now and the future
Tilman D. Rachner et al.
LANCET (2011)
Parathyroid Hormone (PTH)-Induced Bone Gain Is Blunted in SOST Overexpressing and Deficient Mice
Ina Kramer et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Guidelines for Assessment of Bone Microstructure in Rodents Using Micro-Computed Tomography
Mary L. Bouxsein et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Structural Basis for Parathyroid Hormone-related Protein Binding to the Parathyroid Hormone Receptor and Design of Conformation-selective Peptides
Augen A. Pioszak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Altered selectivity of parathyroid hormone (PTH) and PTH-Related protein (PTHrP) for distinct conformations of the PTH/PTHrP receptor
Thomas Dean et al.
MOLECULAR ENDOCRINOLOGY (2008)
Molecular and cellular mechanisms of the anabolic effect of intermittent PTH
Robert L. Jilka
BONE (2007)
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
RM Neer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
